Markets finish week down after bouncing on Bannon's exit >>> READ MORE

CERS CRIS CGEN CPHD – 4 Fab Biotech Stocks on the Fast Track

Continued upside potential for this sector

      View All  


Cerus (CERS) is the world leader in technology and systems to purify blood plasma – purify blood to such a degree blood banks (almost) need not worry about the donor. The company’s products are accepted in many European nations. A new CEO who understands the FDA in the United States is now putting the company on track to get approval in the U.S. – something that should have happened many years ago except for the objections of one FDA staffer – one – in a bad mood the day the Cerus application was being reviewed. Cerus is in development to extend its technology to whole blood, a much bigger market. Hence my enthusiasm.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC